Seed Innovations Limited / AIM: SEED / Sector: Closed End Investments
20th October 2021
SEED Innovations Limited ("SEED" or the "Company")
Holdings in Company
SEED Innovations Limited, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health, and wellness space, announces that Rhonda Abony no longer has a notifiable interest in the Company.
*** ENDS***
For further information on the Company please visit www.seedinnovations.co or contact:
Ed McDermott / Lance de Jersey |
SEED Innovations Ltd |
Email: info@seedinnovations.co
|
James Biddle / Roland Cornish |
Beaumont Cornish Limited, Nomad
|
Tel: +44 (0) 207 628 3396 |
Isabella Pierre / Damon Heath |
Shard Capital Partners LLP
|
T: +44 (0)20 7186 9927 |
Catherine Leftley / Isabel de Salis |
St Brides Partners Ltd, Financial PR
|
Email: info@stbridespartners.co.uk |
Notes
SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.